Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression

Jean Paul Bonnefont, Franco Taroni, Patrizia Cavadini, Claude Cepanec, Michèle Brivet, Jean Marie Saudubray, Jean Paul Leroux, France Demaugre

Research output: Contribution to journalArticle

Abstract

Carnitine palmitoyltransferase (CPT) II deficiency, an inherited disorder of mitochondrial long-chain fatty-acid (LCFA) oxidation, results in two distinct clinical phenotypes, namely, an adult (muscular) form and an infantile (hepatocardiomuscular) form. The rationale of this phenotypic heterogeneity is poorly understood. The adult form of the disease is commonly ascribed to the Ser-113-Leu substitution in CPT II. Only few data are available regarding the molecular basis of the infantile form of the disease. We report herein a homozygous A-2399-C transversion predicting a Tyr-628-Ser substitution in a CPT II-deficient infant. In vitro expression of mutant cDNA in COS-1 cells demonstrated the responsibility of this mutation for the disease. Metabolic consequences of the Ser-113-Leu and Tyr-628-Ser substitutions were studied in fibroblasts. The Tyr-628-Ser substitution (infantile form) resulted in a 10% CPT II residual activity, markedly impairing LCFA oxidation, whereas the Ser-113-Leu substitution (adult form) resulted in a 20% CPT II residual activity, without consequence on LCFA oxidation. These data show that CPT II activity has to be reduced below a critical threshold in order for LCFA oxidation in fibroblasts to be impaired. The hypothesis that this critical threshold differs among tissues could provide a basis to explain phenotypic heterogeneity of CPT II deficiency.

Original languageEnglish
Pages (from-to)971-978
Number of pages8
JournalAmerican Journal of Human Genetics
Volume58
Issue number5
Publication statusPublished - 1996

ASJC Scopus subject areas

  • Genetics

Fingerprint Dive into the research topics of 'Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression'. Together they form a unique fingerprint.

  • Cite this

    Bonnefont, J. P., Taroni, F., Cavadini, P., Cepanec, C., Brivet, M., Saudubray, J. M., Leroux, J. P., & Demaugre, F. (1996). Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression. American Journal of Human Genetics, 58(5), 971-978.